MedTrace Logo

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

NCT02857400 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 667

Last updated 2026-04-14

No results posted yet for this study

Summary

Prospective, open label, randomized and multicentric study evaluating the efficacy of an organized consultation "return home" compared to a current standard of care in patient hospitalized due to metastatic solid tumor cancer.

Subject will be randomized (1:1) as described below :

• Arm A (standard) : current standard of care ; connection documentation faxed to GP ( General practitioner) on the day of patient's discharge Arm B (experimental) : CREDO standard of care, organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP

Conditions

Interventions

OTHER

current standard of care

connection documentation faxed to GP (General practitioner) on the day of patient's discharge

OTHER

CREDO standard of care

organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP

Sponsors & Collaborators

  • Institut Claudius Regaud

    lead OTHER

Principal Investigators

  • Marie-Eve ROUGE BUGAT, MD · Institut Claudius Regaud

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-21
Primary Completion
2022-08-30
Completion
2022-08-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02857400 on ClinicalTrials.gov